Bill > S01817

This bill requires the Office of Addiction Services and Supports (OASAS), a New York state agency responsible for addressing substance use disorders, to proactively support and promote clinical research on ibogaine as a potential treatment for addiction to heroin, methamphetamine, and cocaine. Ibogaine is a psychoactive substance derived from the iboga plant that has shown potential in some preliminary studies for interrupting addictive behaviors, though it remains a controlled substance with significant risks and is not currently approved for medical use in the United States. By mandating that OASAS encourage, aid, and facilitate such research, the bill aims to explore alternative approaches to treating substance use disorders and potentially develop new therapeutic interventions. The legislation would amend the mental hygiene law by adding a specific provision directing the agency to support this targeted research, with the act taking effect immediately upon passage.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/S1817